Today: Today, Oregon Public Employees Retirement Fund invests in UnitedHealth Group Inc. (UNH) Shares

Today, Oregon Public Employees Retirement Fund invests in UnitedHealth Group Inc. (UNH) Shares

Oregon Public Employees Retirement Fund increased its stake in UnitedHealth Group Inc. (NYSE:UNH) by 44.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 340,821 shares of the healthcare conglomerate’s stock after buying an additional 104,705 shares during the period. UnitedHealth Group accounts for approximately 1.0% of Oregon Public Employees Retirement Fund’s holdings, making the stock its 16th largest position. Oregon Public Employees Retirement Fund’s holdings in UnitedHealth Group were worth $47,715,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Van Hulzen Asset Management LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $104,000. Archford Capital Strategies LLC increased its position in shares of UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 696 shares in the last quarter. Hanson McClain Inc. increased its position in shares of UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $126,000 after buying an additional 4 shares in the last quarter. Howe & Rusling Inc. increased its position in shares of UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock valued at $130,000 after buying an additional 40 shares in the last quarter. Finally, Parkside Financial Bank & Trust increased its position in shares of UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 238 shares in the last quarter. Institutional investors and hedge funds own 86.04% of the company’s stock.

UnitedHealth Group Inc. (NYSE:UNH) traded down 0.48% during midday trading on Friday, hitting $152.81. The company had a trading volume of 1,664,542 shares. The company has a market capitalization of $145.45 billion, a P/E ratio of 22.57 and a beta of 0.63. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $154.50. The stock has a 50 day moving average price of $143.37 and a 200 day moving average price of $139.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.09. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The business had revenue of $46.30 billion for the quarter, compared to the consensus estimate of $46.09 billion. During the same period in the prior year, the business posted $1.77 earnings per share. The company’s quarterly revenue was up 11.6% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Friday, December 2nd will be given a dividend of $0.625 per share. The ex-dividend date of this dividend is Wednesday, November 30th. This represents a $2.50 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 36.93%.

Several research analysts have commented on the company. Vetr upgraded UnitedHealth Group from a “buy” rating to a “buy” rating in a research note on Friday, October 7th. Jefferies Group reaffirmed a “buy” rating and issued a $163.00 price target on shares of UnitedHealth Group in a report on Tuesday, October 4th. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Sunday, August 21st. Cowen and Company set a $150.00 price target on UnitedHealth Group and gave the company a “buy” rating in a report on Tuesday, September 6th. Finally, Evercore ISI began coverage on UnitedHealth Group in a report on Thursday, September 22nd. They issued a “buy” rating and a $155.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and twenty-two have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $158.03.

In other news, Director Kenneth Irwin Shine sold 325 shares of the stock in a transaction that occurred on Friday, October 21st. The stock was sold at an average price of $144.99, for a total value of $47,121.75. Following the sale, the director now directly owns 28,613 shares in the company, valued at $4,148,598.87. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Gail R. Wilensky sold 5,460 shares of the stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $150.55, for a total value of $822,003.00. Following the completion of the sale, the director now owns 60,052 shares in the company, valued at $9,040,828.60. The disclosure for this sale can be found here. Company insiders own 1.65% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Related posts

Leave a Comment